Friedhelm Blobel
Directeur/Membre du Conseil chez Entvantage Diagnostics, Inc.
Profil
Friedhelm Blobel is an Independent Non-Executive Director at ImaginAb, Inc. and a Director at Entvantage Diagnostics, Inc. He was previously the President, Chief Executive Officer & Director at SciClone Pharmaceuticals LLC from 2006 to 2017, and at Gryphon Therapeutics, Inc. from 2000 to 2006.
He also served as a Director at Pelikan Technologies, Inc., and as Managing Director at Cosmix molecular biologicals GmbH.
Earlier in his career, he was Group President at Hoechst AG and Roche Diagnostics GmbH.
Blobel received his undergraduate degree from Universität Stuttgart and his doctorate from the University of Hohenheim.
Postes actifs de Friedhelm Blobel
| Sociétés | Poste | Début |
|---|---|---|
Entvantage Diagnostics, Inc.
 Entvantage Diagnostics, Inc. Medical SpecialtiesHealth Technology Entvantage Diagnostics, Inc. develops diagnostic test kits. It includes Collection device and Assay kit products. The company was founded by Joseph Skraba in 2014 and is headquartered in Austin, TX. | Directeur/Membre du Conseil | - |
ImaginAb, Inc.
 ImaginAb, Inc. Medical SpecialtiesHealth Technology ImaginAb, Inc. develops engineered antibody fragments for diagnostic imaging and novel therapeutic applications. It products offer actionable data to facilitate diagnosis of disease, inform better treatment decisions, and monitor response to therapy. The firm also offers a range of pre-clinical (animal imaging) reagents for use with microPET, microSPECT, and optical imaging systems. The company was founded by Christian P. Behrenbruch, Tove Olafsen, Anna M. Wu, and Robert E. Reiter in 2007 and is headquartered in Inglewood, CA. | Directeur/Membre du Conseil | 02/01/2019 |
Anciens postes connus de Friedhelm Blobel
| Sociétés | Poste | Fin |
|---|---|---|
| SCICLONE PHARMACEUTICALS, INC. | Directeur Général | 13/10/2017 |
Gryphon Therapeutics, Inc.
 Gryphon Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Gryphon Therapeutics, Inc. develops and produces protein therapeutics. Its products combine chemically synthesized protein backbones with polyethylene glycols, such as molecules to create potent medications. Gryphon Therapeutics was founded in 1993 and is headquartered in South San Francisco, CA | President | 01/01/2006 |
Cosmix molecular biologicals GmbH
 Cosmix molecular biologicals GmbH BiotechnologyHealth Technology Cosmix molecular biologicals GmbH develops peptides for therapeutics. It identifies and improves peptides for applications in healthcare, research and industry. Cosmix molecular biologicals was founded in 1997 and is headquartered in Braunschweig, Germany. | Corporate Officer/Principal | - |
Roche Diagnostics GmbH
 Roche Diagnostics GmbH Miscellaneous Commercial ServicesCommercial Services Part of Roche Holding AG, Roche Diagnostics GmbH is a German company that develops innovative medicines, treatments, and diagnostics. The company is based in Mannheim, Germany. The CEOs of the company are Claudia Fleischer, Claus Haberda, Clemens Schmid. Roche Diagnostics was acquired by Roche Holding AG on January 01, 1999. | Corporate Officer/Principal | - |
Hoechst AG
 Hoechst AG Chemicals: Major DiversifiedProcess Industries Hoechst AG produced specialty chemicals and pharmaceutical products. It products ranged in areas of heart cycle, thrombose, central nervous system, onkologie, diabetes, metabolic illnesses, internal medicine and vaccines. Founded in 1863, the company was headquartered in Frankfurt am Main, Germany. | Corporate Officer/Principal | - |
Formation de Friedhelm Blobel
| Universität Stuttgart | Undergraduate Degree |
| University of Hohenheim | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 8 |
|---|---|
SciClone Pharmaceuticals LLC
 SciClone Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology SciClone Pharmaceuticals LLC was engaged in the development of therapeutic treatment for oncology, infectious diseases, and cardiovascular disorders. It was also offering ZADAXIN for the treatment of hepatitis B, hepatitis C, certain cancers, and used as immune system enhancer, and DC Bead which is used for the novel treatment of liver cancer. The company was founded in 1990 and was headquartered in San Mateo, CA. | Health Technology |
Hoechst AG
Hoechst AG Chemicals: Major DiversifiedProcess Industries Hoechst AG produced specialty chemicals and pharmaceutical products. It products ranged in areas of heart cycle, thrombose, central nervous system, onkologie, diabetes, metabolic illnesses, internal medicine and vaccines. Founded in 1863, the company was headquartered in Frankfurt am Main, Germany. | Process Industries |
Pelikan Technologies, Inc.
 Pelikan Technologies, Inc. Medical SpecialtiesHealth Technology Pelikan Technologies, Inc. develops hand held diagnostic and monitoring devices. It combines novel and proprietary blood sampling and measurement techniques with state-of-the-art miniaturization and automation technologies to develop superior hand-held medical diagnostic and monitoring devices. The company was founded in 2001 and is headquartered in Palo Alto, CA. | Health Technology |
Roche Diagnostics GmbH
Roche Diagnostics GmbH Miscellaneous Commercial ServicesCommercial Services Part of Roche Holding AG, Roche Diagnostics GmbH is a German company that develops innovative medicines, treatments, and diagnostics. The company is based in Mannheim, Germany. The CEOs of the company are Claudia Fleischer, Claus Haberda, Clemens Schmid. Roche Diagnostics was acquired by Roche Holding AG on January 01, 1999. | Commercial Services |
Gryphon Therapeutics, Inc.
Gryphon Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Gryphon Therapeutics, Inc. develops and produces protein therapeutics. Its products combine chemically synthesized protein backbones with polyethylene glycols, such as molecules to create potent medications. Gryphon Therapeutics was founded in 1993 and is headquartered in South San Francisco, CA | Health Technology |
Cosmix molecular biologicals GmbH
Cosmix molecular biologicals GmbH BiotechnologyHealth Technology Cosmix molecular biologicals GmbH develops peptides for therapeutics. It identifies and improves peptides for applications in healthcare, research and industry. Cosmix molecular biologicals was founded in 1997 and is headquartered in Braunschweig, Germany. | Health Technology |
ImaginAb, Inc.
ImaginAb, Inc. Medical SpecialtiesHealth Technology ImaginAb, Inc. develops engineered antibody fragments for diagnostic imaging and novel therapeutic applications. It products offer actionable data to facilitate diagnosis of disease, inform better treatment decisions, and monitor response to therapy. The firm also offers a range of pre-clinical (animal imaging) reagents for use with microPET, microSPECT, and optical imaging systems. The company was founded by Christian P. Behrenbruch, Tove Olafsen, Anna M. Wu, and Robert E. Reiter in 2007 and is headquartered in Inglewood, CA. | Health Technology |
Entvantage Diagnostics, Inc.
Entvantage Diagnostics, Inc. Medical SpecialtiesHealth Technology Entvantage Diagnostics, Inc. develops diagnostic test kits. It includes Collection device and Assay kit products. The company was founded by Joseph Skraba in 2014 and is headquartered in Austin, TX. | Health Technology |
